First Episode Psychosis and Pathway to Care in Nordland

First Episode Psychosis Clinical Trial

Official title:

Patients and Carers Experiences With First Episode Psychosis and Pathway to Care in Nordland: A Qualitative Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01753284
• Other study ID #: 2012/1650(REK)
• Status: Completed
• Start date: January 2013
• Est. completion date: December 2018

Study information

• Verified date: April 2018
• Source: Nordlandssykehuset HF
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

First episode psychosis patients often experiences treatment delay. This reduces their prospects for recovery and makes unnecessary burdens for them and their carers. A better understanding of help seeking intentions is required, and has not been explored in a county like Nordland, Norway, with long distances and challenging access to health services. The purpose of this study is to explore the process of help seeking, including how patients and their careers discover and understand the psychotic symptoms. Research exploring the impact on families mainly focuses on parents` experiences, and there are less studies focusing on experiences and needs of siblings. This study will therefore explore siblings` experiences separate from their parents. Methods will be qualitative interviews with patients, their carers and siblings. Analysis will be influenced by Grounded theory.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: December 2018
• Est. primary completion date: October 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 16 Years to 35 Years

Eligibility

Inclusion Criteria:

• age 16-35,

• understand and speak Norwegian

• able to give consent

• no learning disabilities

Exclusion Criteria:

Related Conditions & MeSH terms

• First Episode Psychosis
• Mental Disorders
• Psychotic Disorders

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Nordlandssykehuset HF

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient experience		up to 100 weeks
Primary	Carers experiences		up to 100 weeks
Primary	Siblings experiences		up to 100 weeks
Primary	Pathway to care		up to 100 weeks